Genomic analyses identify molecular subtypes of pancreatic cancer
2016 · Nature · 3,651 citations
https://doi.org/10.1038/nature16965
M
Mark Pinese
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
159
Papers
19.9K
Citations
47
h-index
67
i10-index
Mark Pinese is an academic researcher from The University of Sydney. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Pancreatic and Hepatic Oncology Research & Genomics and Rare Diseases. The author has an h-index of 47, co-authored 136 publications.
ORCID: 0000-0001-5078-6687Papers by this author
worksThe repertoire of mutational signatures in human cancer
2020 · Nature · 3,614 citations
https://doi.org/10.1038/s41586-020-1943-3
Whole genomes redefine the mutational landscape of pancreatic cancer
2015 · Nature · 2,610 citations
https://doi.org/10.1038/nature14169
Genomic basis for RNA alterations in cancer
2020 · Nature · 419 citations
https://doi.org/10.1038/s41586-020-1970-0
Targeting the <scp>LOX</scp> / <scp>hypoxia</scp> axis reverses many of the features that make pancreatic cancer deadly: inhibition of <scp>LOX</scp> abrogates metastasis and enhances drug efficacy
2015 · EMBO Molecular Medicine · 259 citations
https://doi.org/10.15252/emmm.201404827
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
2020 · Nature Communications · 232 citations
https://doi.org/10.1038/s41467-019-13825-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat